Sign up to save your podcasts
Or
Share Behind the landmark WHO decision on essential medicines for MS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Behind the landmark WHO decision on essential medicines for MS
Multiple sclerosis (MS) treatments have been successfully added onto the World Health Organisation's Essential Medicines List (EML) in July 2023. Nick Rijke of the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss the impact of this milestone and the next steps for clinicians, researchers, patients, and the MS community at large.
View all episodes
By The European Committee for Treatment and Research in Multiple Sclerosis
4.5
22 ratings
Multiple sclerosis (MS) treatments have been successfully added onto the World Health Organisation's Essential Medicines List (EML) in July 2023. Nick Rijke of the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss the impact of this milestone and the next steps for clinicians, researchers, patients, and the MS community at large.
More shows like The ECTRIMS Podcast
View all
Neurology® Podcast
292 Listeners
Practical Neurology Podcast
50 Listeners
In The Dark
28,485 Listeners
The Daily
112,200 Listeners
RealTalk MS
149 Listeners
Shameless
866 Listeners
Living Well with Multiple Sclerosis
50 Listeners
Post Reports
5,457 Listeners
The Journal.
6,081 Listeners
MS Living Well: Key Info from Multiple Sclerosis Experts
124 Listeners
ZOE Science & Nutrition
2,069 Listeners
Continuum Audio
82 Listeners